30
Participants
Start Date
December 5, 2019
Primary Completion Date
May 17, 2022
Study Completion Date
March 1, 2023
Meso Wound Matrix
"Subjects who meet eligibility criteria will receive standard of care and Meso Wound Matrix.~The standard of care therapy in this study is offloading of the DFU, appropriate sharp or surgical debridement, and aggressive infection management with the use of appropriate dressings. Total contact casting or fixed ankle walker will be used for off-loading. Wound Matrix is an acellular scaffold to reinforce and repair soft tissue defects. Subjects may receive up to eight applications of Meso Wound Matrix. Subjects whose study ulcer does not heal after eight applications will receive only SOC treatment for 4 additional weeks."
D&P Medical Group, Pittsburgh
Foot & Ankle Wellness Clinic, Ford City
Royal Research, Pembroke Pines
Collaborators (1)
DSM Biomedical, Inc.
UNKNOWN
SerenaGroup, Inc.
NETWORK